Trial Profile
A retrospective study to evaluate the treatment response to tocilizumab by measuring the neutrophil lymphocyte ratio in patients with rheumatoid arthritis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Feb 2016
Price :
$35
*
At a glance
- Drugs Tocilizumab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 09 Feb 2016 New trial record